Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.875 GBX | +7.63% | +11.58% | +19.84% |
Apr. 10 | FTSE 100 Closes Up 0.3% as U.S. Uncertainty Boosts Appetite for U.K. Stocks | DJ |
Apr. 10 | E-Therapeutics says company faces lack of interest as UK listing | AN |
Financials (USD)
Sales 2022 | 0.48 | Sales 2023 | 0.48 | Capitalization | 93.73M |
---|---|---|---|---|---|
Net income 2022 | -8M | Net income 2023 | -8M | EV / Sales 2022 | 306,956,621 x |
Net cash position 2022 | 25.96M | Net cash position 2023 | 31.39M | EV / Sales 2023 | 131,228,741 x |
P/E ratio 2022 |
-20.3
x | P/E ratio 2023 |
-10.5
x | Employees | 34 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.56% |
1 day | +7.63% | ||
1 week | +11.58% | ||
Current month | -10.23% | ||
1 month | -8.14% | ||
3 months | -45.21% | ||
6 months | -3.99% | ||
Current year | +19.84% |
Managers | Title | Age | Since |
---|---|---|---|
Ahmad Mortazavi
CEO | Chief Executive Officer | 53 | 20-01-31 |
Director of Finance/CFO | - | - | |
Alan Whitmore
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Jones
CHM | Chairman | 82 | 15-10-27 |
Director/Board Member | 68 | 20-02-10 | |
Ahmad Mortazavi
CEO | Chief Executive Officer | 53 | 20-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 9.875 | +7.63% | 327 887 |
24-04-29 | 9.175 | -6.38% | 1,444,749 |
24-04-26 | 9.8 | +2.08% | 2,327,452 |
24-04-25 | 9.6 | +4.63% | 2,228,014 |
24-04-24 | 9.175 | +3.67% | 2,186,052 |
Delayed Quote London S.E., April 30, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+19.84% | 67.29M | |
+0.25% | 42.86B | |
+11.96% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.31% | 25.15B | |
-24.11% | 18.63B | |
+27.34% | 12.37B | |
-3.80% | 11.92B | |
+7.14% | 11.21B |
- Stock Market
- Equities
- ETX Stock